|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:alsoKnownAs
|
gptkb:Roche
|
|
gptkbp:CEO
|
gptkb:Thomas_Schinecker
|
|
gptkbp:chairman
|
gptkb:Christoph_Franz
|
|
gptkbp:foundedBy
|
gptkb:Fritz_Hoffmann-La_Roche
|
|
gptkbp:foundedYear
|
1896
|
|
gptkbp:headquartersLocation
|
gptkb:Switzerland
Basel
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Hoffmann-La Roche
|
|
gptkbp:industry
|
Pharmaceuticals
Diagnostics
|
|
gptkbp:ISIN
|
CH0012032048
|
|
gptkbp:logo
|
Roche_Logo.svg
|
|
gptkbp:marketCapitalization2023
|
over CHF 200 billion
|
|
gptkbp:memberOf
|
gptkb:International_Federation_of_Pharmaceutical_Manufacturers_&_Associations
gptkb:European_Federation_of_Pharmaceutical_Industries_and_Associations
|
|
gptkbp:netIncome
|
CHF 13.5 billion
|
|
gptkbp:notableEvent
|
Development of COVID-19 diagnostics
Acquisition of Chugai Pharmaceutical
Acquisition of Flatiron Health
Acquisition of Foundation Medicine
Acquisition of Genentech in 2009
|
|
gptkbp:notablePerson
|
gptkb:André_Hoffmann
gptkb:Arthur_D._Levinson
gptkb:William_Burns
gptkb:John_C._Martin
gptkb:Paul_Sacher
gptkb:Levi_Garraway
gptkb:Severin_Schwan
gptkb:Alan_Hippe
gptkb:Beatrice_Weder_di_Mauro
gptkb:Emil_Barell
gptkb:Franz_Humer
gptkb:Jörg_Duschmalé
gptkb:Jean-Jacques_Garaud
gptkb:Maja_Oeri
gptkb:Shanthi_Ganeshan
gptkb:Teresa_Graham
gptkb:William_M._Burns
gptkb:William_Pao
gptkb:Luc_Hoffmann
gptkb:Fritz_Hoffmann-La_Roche
gptkb:James_Sabry
|
|
gptkbp:notableProduct
|
gptkb:Evrysdi
gptkb:Phesgo
gptkb:Ronapreve
gptkb:Enspryng
gptkb:Lucentis
gptkb:Venclexta
gptkb:Actemra
gptkb:Alecensa
gptkb:Avastin
gptkb:Bonviva
gptkb:Cellcept
gptkb:Cotellic
gptkb:Esbriet
gptkb:Gazyva
gptkb:Hemlibra
gptkb:Herceptin
gptkb:Kadcyla
gptkb:MabThera
gptkb:Ocrevus
gptkb:Pegasys
gptkb:Perjeta
gptkb:Polivy
gptkb:Rituxan
gptkb:Rocephin
gptkb:Rozlytrek
gptkb:Tamiflu
gptkb:Tecentriq
gptkb:Valium
gptkb:Xeloda
gptkb:Xenical
gptkb:Zelboraf
|
|
gptkbp:notableWinner
|
gptkb:Prix_Galien
|
|
gptkbp:numberOfEmployees
|
over 100,000
|
|
gptkbp:parentCompany
|
gptkb:Roche_Holding_AG
|
|
gptkbp:revenue
|
CHF 58.7 billion
|
|
gptkbp:servesArea
|
Worldwide
|
|
gptkbp:stockExchange
|
gptkb:SIX_Swiss_Exchange
|
|
gptkbp:stockSymbol
|
gptkb:ROG
|
|
gptkbp:subsidiary
|
gptkb:Genentech
gptkb:Foundation_Medicine
gptkb:Chugai_Pharmaceutical
gptkb:Flatiron_Health
|
|
gptkbp:website
|
https://www.roche.com
|
|
gptkbp:bfsParent
|
gptkb:zalcitabine
gptkb:Flumazenil
gptkb:Benzodiazepines
gptkb:Hadassah_Lieberman
gptkb:flumazenil
gptkb:Seveso_disaster
gptkb:Fritz_Hoffmann-La_Roche
gptkb:ceftriaxone
gptkb:Ceftriaxone
|
|
gptkbp:bfsLayer
|
6
|